Your nerves and blood vessels use the CALCB gene to make part of CGRP, a signaling protein that helps control pain signals and the widening of blood vessels. If this gene does not work as expected, these signals may become less balanced and may contribute to headache conditions such as migraine. This gene plays an important role in how the nervous system and blood vessels communicate. The CALCB gene is better known in medicine than in popular culture, mainly because CGRP blocking drugs are used to treat migraine.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, which do much of the cell’s work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
CALCBGene function
What if the gene works
The CALCB gene helps make β-CGRP, a signaling protein used by nerve cells. This protein helps control blood vessel widening and pain signaling.
Risk
What if the gene does not work
Changes in the CALCB gene can lead to low or altered β-CGRP, a nerve signal that helps control blood vessel tone and pain signaling. Milder to more severe variants may reduce how well this signal is made, released, or recognized.
Treatment
What does that mean for your treatment
No CALCB-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the CALCB gene. The CALCB gene is part of the CGRP pathway, which is a drug target in migraine care, but those medicines are not selected based on a CALCB variant.
Gene function
What if the gene works
In your body, the CALCB gene helps certain nerve cells send a small chemical message. That message is used in day to day control of blood vessel tone and sensory signaling. This background helps explain how the CALCB gene supports blood flow and pain signaling in everyday life.
The CALCB gene provides instructions for a small messenger protein called beta CGRP. Certain nerve cells release this signal so nearby cells can adjust their activity.
Beta CGRP can relax the muscle in blood vessel walls, which helps them widen. This supports healthy blood flow and normal control of circulation.
This signal also helps carry sensory messages, including some linked to pain. That is part of how the body detects and responds to irritation or injury.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences among people, including appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CALCB gene can change how much CGRPβ a cell makes, how well its RNA is spliced and processed, or how the final signaling peptide is folded, released, and binds its receptor. This summary of how CALCB gene variants affect the peptide's function reflects a spectrum: milder variants may only slightly reduce signaling, while more severe variants can markedly lower peptide production or make the peptide unstable or inactive.
How variants are linked to conditions
The CALCB gene does not yet have a broadly confirmed link to a specific health condition, although research on CALCB gene variants and disease risk is still developing. Anyone with a confirmed variant in the CALCB gene should use their own test report and guidance from their doctor or genetic counselor to understand what it may mean for them.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to CALCB. Anyone with concerns about what this gene may mean for their health or family risk should speak with a doctor or genetic counselor.
Inheritance of CALCB variants
There is not yet a broadly confirmed Mendelian pattern for CALCB-related disease, so CALCB gene inheritance is not described as a well-established autosomal dominant, autosomal recessive, or X-linked condition. As research develops, this may become clearer. The CALCB gene is located on chromosome 11, which is an autosome, so you inherit one copy from each parent. That means changes in this gene, if they matter clinically, would be passed through the usual inheritance patterns seen for genes on non-sex chromosomes.
What does my CALCB result mean for my family?
There is not yet a broadly confirmed inherited pattern linking CALCB to a specific recognized genetic condition in families, though this can change as research moves forward. If you have a specific CALCB result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
CALCB genetic testing for gene variants usually uses a blood or saliva sample. A laboratory reads the CALCB gene, often within a multigene panel or broader DNA sequencing test, and compares it with the usual sequence to identify variants and classify them as benign, uncertain, or linked to disease.
When should I consider getting a genetic test?
There is not yet a broadly established CALCB-specific reason for genetic testing in routine care. Decisions about testing are usually based on your symptoms, family history, and whether a doctor or genetic counselor thinks a broader test could be helpful.
A genetic result is only one part of your health story
How informative a genetic result is varies with the condition and with the specific kind of variant involved. Over time, the way the body functions is also shaped by factors like age, lifestyle, environment, and medical history. With some conditions, particularly those linked to many genes, genetic information offers context rather than certainty and makes the most sense when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in DNA can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes side effects more easily in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It focuses on patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence both how strongly a drug acts and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CALCB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
In the 1980s, researchers identified the CALCB gene while sorting out a family of closely related genes linked to calcitonin gene related peptides. Early work showed that CALCB was distinct from the CALCA gene, which helped clarify why similar peptide signals could come from different genetic sources. From these first observations, research expanded steadily. Interest in this area grew further as calcitonin gene related peptides became important in headache and migraine research, bringing more attention to the genes behind them. Although CALCB has stayed less familiar to the public than some other genes, its discovery helped shape a broader chapter in modern neurobiology and pain research.